✦ LIBER ✦

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

✍ Scribed by Christian Elger; Peter Halász; Joana Maia; Luis Almeida; Patrício Soares-da-Silva; on behalf of the BIA-2093-301 Investigators Study Group

Book ID: 109111101
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Tongue: English
Weight: 337 KB
Volume: 50
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1167.2008.01946.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures

✍ Victor Biton; Gregory Krauss; Blanca Vasquez-Santana; Francesco Bibbiani; Alliso 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 222 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures

✍ Jonathan J. Halford; Elinor Ben-Menachem; Patrick Kwan; Seth Ness; Jennifer Schm 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 459 KB

Once-daily extended-release levetiraceta

Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: A double-blind, randomized, placebo-controlled trial

✍ Jukka Peltola; Christo Coetzee; Fiacro Jiménez; Tetyana Litovchenko; Sridharan R 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 297 KB

Efficacy and Safety of Levetiracetam (up

Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double-blind, Placebo-controlled Study

✍ Jing-Jane Tsai; Der-Jen Yen; Mo-Song Hsih; Shung-Sheng Chen; Reinhard Hiersemenz 📂 Article 📅 2006 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 168 KB

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

✍ Lee S. Rosen; David Gordon; N. Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views